Hui Zheng - Concepedia

Author

Hui Zheng

Chinese Center For Disease Control and Prevention ORCID

Also Known As

H Zheng, Hui Zheng, Hui-zhen Zheng, Zheng, Hui

Publications

691

Citations

H-Index

Concepts

All Affiliations

Chinese Center For Disease Control and Prevention Peking University Second Military Medical University Guangzhou Center for Disease Control and Prevention Center for Disease Control

About

Hui Zheng is an author at Chinese Center For Disease Control and Prevention specializing in medicine, vaccination, and vaccine safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	362
2	Public Health	3	3	214
3	Engineering	1	1	19
4	Chemical Engineering	1	1	19
5	Chemistry	1	1	19

Hui Zheng

Publications

583

Citations

H-Index

Page 1

	Year	Citations
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study Chao Wang, Bingfeng Han, Tianshuo Zhao, Vaccine VaccinationPreventive MedicineGlobal HealthCovid-19 PandemicVaccine Efficacy	2021	167
[Human natural infection of Plasmodium knowlesi]. Huaimin Zhu, Jun Li, Hui Zheng PubMed Emerging Infectious DiseasesAfrican TrypanosomiasisPathogenesisHematologyMalaria	2006	81
Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence — China, 2021 Dan Wu, Yanyang Zhang, Lin Tang, China CDC Weekly	2022	56
Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force Survey Dena L. Schanzer, Hui Zheng, Jason Gilmore BMC Infectious Diseases	2011	52
Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022 Mingshuang Li, Qianqian Liu, Dan Wu, China CDC Weekly	2022	50
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial Rong Tang, Hui Zheng, Busen Wang, The Lancet Respiratory Medicine VaccinationVaccine SafetyVaccine DevelopmentPhase 4Immunology	2023	48
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021 Chao Ma, Weiwei Sun, Tingting Tang, Vaccine VaccinationVaccine SafetyVirus EpidemiologyEmerging Infectious DiseasesMedicine	2022	35
Real-World Effectiveness of Primary Series and Booster Doses of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2 Variant Infection in China: A Retrospective Cohort Study Lin Tang, Fuzhen Wang, Lance E. Rodewald, The Journal of Infectious Diseases	2023	20
Trace Analysis Method Based on UPLC–MS/MS for the Determination of (C2–C18) Per-and Polyfluoroalkyl Substances and Its Application to Tap Water and Bottled Water Bingqi Dong, Jing Wu, Yiru Zhuang, Analytical Chemistry Ammonium AcetateEngineeringChemistryTrace Analysis MethodBottled Water	2023	19
Effectiveness of Catch-Up Vaccinations after COVID-19 Containment — China, 2020 Jing Wu, Wenzhou Yu, Lei Cao, China CDC Weekly	2020	13

Page 1